Novartis AG (STU:NOTA) Stock News, Headlines & Updates
Novartis AG Stock News from GuruFocus
- 1
Jul 09, 2025
Novartis (NVS) Secures Exclusive Option on Sironax's Brain Delivery Technology | NVS Stock News
GuruFocus News • 7:33am
Jul 08, 2025
Novartis (NVS) Gains Approval for Infant Malaria Treatment
GuruFocus News • 3:56am
Jul 03, 2025
Novartis (NVS): Cosentyx Falls Short in Key Phase 3 Trial for GCA
GuruFocus News • 6:57am
Novartis AG (NVS) Announces Phase III GCAptAIN Study Results for Cosentyx | NVS stock news
GuruFocus News • 2:01am
Novartis provides update on Phase III GCAptAIN study of Cosentyx® in giant cell arteritis (GCA)
PRNewswire • 1:00am
Novartis provides update on Phase III GCAptAIN study of Cosentyx® in giant cell arteritis (GCA) | NVS Stock News
GuruFocus News • 12:45am
Jun 26, 2025
Novartis (NVS) Partners with ProFound for Cardiovascular Drug Development
GuruFocus News • 10:56am
Jun 25, 2025
Novartis (NVS) Completes Acquisition of Regulus Therapeutics | NVS Stock News
GuruFocus News • 8:45am
Novartis (NVS) Concludes Acquisition Offer for Regulus Therapeutics | NVS Stock News
GuruFocus News • 5:48am
Jun 23, 2025
Novartis (NVS) Advances in Acquisition with Key Regulatory Approval | NVS Stock News
GuruFocus News • 12:31pm
Jun 12, 2025
Novartis (NVS) Reports Positive Outcomes in Phase IIIB Fabhalta Study | NVS Stock News
GuruFocus News • 5:31am
Jun 11, 2025
Novartis AG (NVS) Announces Promising Phase III Trial Results for Prostate Cancer Treatment | NVS stock news
GuruFocus News • 8:08am
Global Billion Dollar Oncology Industry Experiencing Substantial Growth Driven by Increasing Cancer Incidences
Marketwired • 8:00am
Jun 02, 2025
Novartis (NVS) Reports Positive Interim Results in Prostate Cancer Trial | NVS Stock News
GuruFocus News • 6:17am
Jun 01, 2025
Novartis (NVS) Highlights Positive Results from Kisqali Study in Treating Early Breast Cancer | NVS Stock News
GuruFocus News • 6:45pm
May 12, 2025
Novartis (NVS) Commits to Uninterrupted Production of Essential Medicines | NVS Stock News
GuruFocus News • 5:31am
May 03, 2025
Novartis (NVS) To Acquire Regulus Therapeutics in $0.8 Billion Deal
GuruFocus News • 2:55pm
Apr 30, 2025
Novartis (NVS) Agrees to Acquire Regulus at a Premium Price | NVS Stock News
GuruFocus News • 8:32am
Novartis (NVS) to Acquire Regulus Therapeutics in $0.8B Deal | NVS Stock News
GuruFocus News • 6:32am
Novartis AG (NVS) Q1 2025 Earnings Call Highlights: Impressive Growth and Strategic Advancements
GuruFocus News • 1:06am
Q1 2025 Novartis AG Earnings Call Transcript
GuruFocus News • 11:03pm
Apr 29, 2025
Novartis (NVS) Q1 Revenue Surpasses Expectations, Driven by Strong Sales and Innovation | NVS Stock News
GuruFocus News • 10:16am
Novartis (NVS) Boosts 2025 Outlook with Promising Growth Forecast | NVS Stock News
GuruFocus News • 10:15am
Novartis (NVS) Surpasses Q1 Expectations, Updates 2025 Outlook
GuruFocus News • 12:57am
Apr 28, 2025
Novartis (NVS) Poised for Q1 Earnings Beat Amid Upward Revisions
GuruFocus News • 1:58pm
HSBC Lowers Novartis (NVS) Price Target Amid Tariff and Patent Concerns | NVS Stock News
GuruFocus News • 6:17am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news